{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:12:46Z","timestamp":1793923966736,"version":"4.8.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T00:00:00Z","timestamp":1493164800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals, Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s40257-017-0284-y","type":"journal-article","created":{"date-parts":[[2017,4,26]],"date-time":"2017-04-26T05:39:57Z","timestamp":1493185197000},"page":"825-835","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Discordance Between Physician- and Patient-Reported Disease Severity in Adults with Atopic Dermatitis: A US Cross-Sectional Survey"],"prefix":"10.1007","volume":"18","author":[{"given":"Wenhui","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijit","family":"Gadkari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Blackburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Piercy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashank","family":"Shinde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Ghorayeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,26]]},"reference":[{"issue":"1","key":"284_CR1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1600-065X.2011.01027.x","volume":"242","author":"M Boguniewicz","year":"2011","unstructured":"Boguniewicz M, Leung DY. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev. 2011;242(1):233\u201346.","journal-title":"Immunol Rev"},{"issue":"1","key":"284_CR2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/all.12268","volume":"69","author":"SC Dharmage","year":"2014","unstructured":"Dharmage SC, Lowe AJ, Matheson MC, et al. Atopic dermatitis and the atopic march revisited. Allergy. 2014;69(1):17\u201327.","journal-title":"Allergy"},{"issue":"4","key":"284_CR3","first-page":"403","volume":"151","author":"M Napolitano","year":"2016","unstructured":"Napolitano M, Megna M, Patruno C, et al. Adult atopic dermatitis: a review. G Ital Dermatol Venereol. 2016;151(4):403\u201311.","journal-title":"G Ital Dermatol Venereol."},{"issue":"14","key":"284_CR4","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1056\/NEJMra074081","volume":"358","author":"T Bieber","year":"2008","unstructured":"Bieber T. Atopic dermatitis. N Engl J Med. 2008;358(14):1483\u201394.","journal-title":"N Engl J Med"},{"issue":"3","key":"284_CR5","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jaci.2014.11.023","volume":"135","author":"JI Silverberg","year":"2015","unstructured":"Silverberg JI, Greenland P. Eczema and cardiovascular risk factors in 2 US adult population studies. J Allergy Clin Immunol. 2015;135(3):721\u20138.","journal-title":"J Allergy Clin Immunol."},{"issue":"5","key":"284_CR6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.18553\/jmcp.2002.8.5.333","volume":"8","author":"D Fivenson","year":"2002","unstructured":"Fivenson D, Arnold RJ, Kaniecki DJ, et al. The effect of atopic dermatitis on total burden of illness and quality of life on adults and children in a large managed care organization. J Manag Care Pharm. 2002;8(5):333\u201342.","journal-title":"J Manag Care Pharm."},{"issue":"1","key":"284_CR7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-4632.2004.02345.x","volume":"45","author":"M Barbeau","year":"2006","unstructured":"Barbeau M, Lalonde H. Burden of atopic dermatitis in Canada. Int J Dermatol. 2006;45(1):31\u20136.","journal-title":"Int J Dermatol"},{"issue":"2","key":"284_CR8","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1529-8019.2006.00060.x","volume":"19","author":"SL Chamlin","year":"2006","unstructured":"Chamlin SL. The psychosocial burden of childhood atopic dermatitis. Dermatol Ther. 2006;19(2):104\u20137.","journal-title":"Dermatol Ther"},{"issue":"4","key":"284_CR9","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/jid.2014.530","volume":"135","author":"FJ Dalgard","year":"2015","unstructured":"Dalgard FJ, Gieler U, Tomas-Aragones L, et al. The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries. J Invest Dermatol. 2015;135(4):984\u201391.","journal-title":"J Invest Dermatol."},{"issue":"3","key":"284_CR10","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1067\/mai.2003.174","volume":"111","author":"BG Bender","year":"2003","unstructured":"Bender BG, Leung SB, Leung DY. Actigraphy assessment of sleep disturbance in patients with atopic dermatitis: an objective life quality measure. J Allergy Clin Immunol. 2003;111(3):598\u2013602.","journal-title":"J Allergy Clin Immunol."},{"issue":"4","key":"284_CR11","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/13548500601073928","volume":"12","author":"A Wittkowski","year":"2007","unstructured":"Wittkowski A, Richards HL, Griffiths CE, Main CJ. Illness perception in individuals with atopic dermatitis. Psychol Health Med. 2007;12(4):433\u201344.","journal-title":"Psychol Health Med."},{"issue":"2","key":"284_CR12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jdermsci.2013.06.010","volume":"72","author":"C Yano","year":"2013","unstructured":"Yano C, Saeki H, Ishiji T, et al. Impact of disease severity on sleep quality in Japanese patients with atopic dermatitis. J Dermatol Sci. 2013;72(2):195\u20137.","journal-title":"J Dermatol Sci"},{"issue":"9","key":"284_CR13","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/1346-8138.12220","volume":"40","author":"C Yano","year":"2013","unstructured":"Yano C, Saeki H, Ishiji T, et al. Impact of disease severity on work productivity and activity impairment in Japanese patients with atopic dermatitis. J Dermatol. 2013;40(9):736\u20139.","journal-title":"J Dermatol"},{"issue":"3","key":"284_CR14","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jaad.2015.10.043","volume":"74","author":"EL Simpson","year":"2016","unstructured":"Simpson EL, Bieber T, Eckert L, et al. Patient burden of moderate-to-severe atopic dermatitis: insights from a phase 2b clinical trial of dupilumab in adults. J Am Acad Dermatol. 2016;74(3):491\u20138.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"284_CR15","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jaad.2016.05.028","volume":"75","author":"JP Kim","year":"2016","unstructured":"Kim JP, Chao LX, Simpson EL, Silverberg JI. Persistence of atopic dermatitis (AD): a systematic review and meta-analysis. J Am Acad Dermatol. 2016;75(4):681\u20137.","journal-title":"J Am Acad Dermatol"},{"key":"284_CR16","unstructured":"The World Allergy Organization. The World Allergy Organization white book on allergy: 2013 update. Available from: http:\/\/www.worldallergy.org\/UserFiles\/file\/WhiteBook2-2013-v8.pdf . Accessed 13 Apr 2017."},{"issue":"4","key":"284_CR17","doi-asserted-by":"crossref","first-page":"e17520","DOI":"10.1371\/journal.pone.0017520","volume":"6","author":"B Rehal","year":"2011","unstructured":"Rehal B, Armstrong AW. Health outcome measures in atopic dermatitis: a systematic review of trends in disease severity and quality-of-life instruments 1985\u20132010. PLoS One. 2011;6(4):e17520.","journal-title":"PLoS One"},{"issue":"4","key":"284_CR18","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jaci.2014.07.043","volume":"134","author":"J Schmitt","year":"2014","unstructured":"Schmitt J, Spuls PI, Thomas KS, et al. The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials. J Allergy Clin Immunol. 2014;134(4):800\u20137.","journal-title":"J Allergy Clin Immunol."},{"issue":"5","key":"284_CR19","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/bjd.13662","volume":"172","author":"YA Leshem","year":"2015","unstructured":"Leshem YA, Hajar T, Hanifin JM, Simpson EL. What the Eczema Area and Severity Index score tells us about the severity of atopic dermatitis: an interpretability study. Br J Dermatol. 2015;172(5):1353\u20137.","journal-title":"Br J Dermatol"},{"issue":"1","key":"284_CR20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000245677","volume":"195","author":"B Kunz","year":"1997","unstructured":"Kunz B, Oranje AP, Labreze L, et al. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology. 1997;195(1):10\u20139.","journal-title":"Dermatology"},{"issue":"2","key":"284_CR21","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jaad.2015.09.062","volume":"74","author":"M Futamura","year":"2016","unstructured":"Futamura M, Leshem YA, Thomas KS, et al. A systematic review of Investigator Global Assessment (IGA) in atopic dermatitis (AD) trials: many options, no standards. J Am Acad Dermatol. 2016;74(2):288\u201394.","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"284_CR22","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1185\/03007990802457040","volume":"24","author":"P Anderson","year":"2008","unstructured":"Anderson P, Benford M, Harris N, et al. Real-world physician and patient behaviour across countries: disease-specific programmes: a means to understand. Curr Med Res Opin. 2008;24(11):3063\u201372.","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"284_CR23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1034\/j.1600-0625.2001.100102.x","volume":"10","author":"JM Hanifin","year":"2001","unstructured":"Hanifin JM, Thurston M, Omoto M, et al. The Eczema Area and Severity Index (EASI): assessment of reliability in atopic dermatitis: EASI Evaluator Group. Exp Dermatol. 2001;10(1):11\u20138.","journal-title":"Exp Dermatol"},{"issue":"12","key":"284_CR24","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1001\/archderm.140.12.1513","volume":"140","author":"CR Charman","year":"2004","unstructured":"Charman CR, Venn AJ, Williams HC. The patient-oriented eczema measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients\u2019 perspective. Arch Dermatol. 2004;140(12):1513\u20139.","journal-title":"Arch Dermatol"},{"issue":"3","key":"284_CR25","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","volume":"19","author":"AY Finlay","year":"1994","unstructured":"Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210\u20136.","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"284_CR26","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2340\/00015555-1246","volume":"92","author":"NQ Phan","year":"2012","unstructured":"Phan NQ, Blome C, Fritz F, et al. Assessment of pruritus intensity: prospective study on validity and reliability of the visual analogue scale, numerical rating scale and verbal rating scale in 471 patients with chronic pruritus. Acta Derm Venereol. 2012;92(5):502\u20137.","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"284_CR27","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2133.2009.09586.x","volume":"162","author":"S Elman","year":"2010","unstructured":"Elman S, Hynan LS, Gabriel V, Mayo MJ. The 5-D itch scale: a new measure of pruritus. Br J Dermatol. 2010;162(3):587\u201393.","journal-title":"Br J Dermatol"},{"issue":"3","key":"284_CR28","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","volume":"16","author":"The EuroQol Group","year":"1990","unstructured":"The EuroQol Group. EuroQol: a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199\u2013208.","journal-title":"Health Policy"},{"issue":"3","key":"284_CR29","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00005650-200503000-00003","volume":"43","author":"JW Shaw","year":"2005","unstructured":"Shaw JW, Johnson JA, Coons SJ. US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care. 2005;43(3):203\u201320.","journal-title":"Med Care"},{"key":"284_CR30","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","volume":"4","author":"MC Reilly","year":"1993","unstructured":"Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4:353\u201365.","journal-title":"Pharmacoeconomics."},{"key":"284_CR31","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale: Lawrence Erlbaum Associates; 1988.","edition":"2"},{"key":"284_CR32","unstructured":"Huber PJ. The behavior of maximum likelihood estimates under nonstandard conditions. In: Proceedings of the fifth Berkeley symposium on mathematical statistics and probability. Berkeley: University of California Press; 1967. p. 221\u201333."},{"key":"284_CR33","volume-title":"The analysis of binary data","author":"DR Cox","year":"1989","unstructured":"Cox DR, Snell EJ. The analysis of binary data. 2nd ed. London: Chapman and Hall; 1989.","edition":"2"},{"issue":"3","key":"284_CR34","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/biomet\/78.3.691","volume":"78","author":"NJD Nagelkerke","year":"1991","unstructured":"Nagelkerke NJD. A note on a general definition of the coefficient of determination. Biometrika. 1991;78(3):691\u20132.","journal-title":"Biometrika"},{"issue":"1","key":"284_CR35","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1684\/ejd.2011.1560","volume":"22","author":"A Torrelo","year":"2012","unstructured":"Torrelo A, Ortiz J, Alomar A, et al. Atopic dermatitis: impact on quality of life and patients\u2019 attitudes toward its management. Eur J Dermatol. 2012;22(1):97\u2013105.","journal-title":"Eur J Dermatol."},{"issue":"4","key":"284_CR36","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3111\/13696998.2011.583703","volume":"14","author":"AG Bushmakin","year":"2011","unstructured":"Bushmakin AG, Cappelleri JC, Taylor-Stokes G, et al. Relationship between patient-reported disease severity and other clinical outcomes in osteoarthritis: a European perspective. J Med Econ. 2011;14(4):381\u20139.","journal-title":"J Med Econ."},{"issue":"6","key":"284_CR37","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/acr.20132","volume":"62","author":"JL Barton","year":"2010","unstructured":"Barton JL, Imboden J, Graf J, et al. Patient-physician discordance in assessments of global disease severity in rheumatoid arthritis. Arthritis Care Res (Hoboken). 2010;62(6):857\u201364.","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"284_CR38","first-page":"401","volume":"4","author":"G Taylor-Stokes","year":"2011","unstructured":"Taylor-Stokes G, Pike J, Sadosky A, et al. Association of patient-rated severity with other outcomes in patients with painful diabetic peripheral neuropathy. Diabetes Metab Syndr Obes. 2011;4:401\u20138.","journal-title":"Diabetes Metab Syndr Obes."},{"issue":"3","key":"284_CR39","first-page":"1048","volume":"3","author":"C Paul","year":"2015","unstructured":"Paul C, Bushmakin AG, Cappelleri JC, et al. Do patients and physicians agree in their assessment of the severity of psoriasis? Insights from tofacitinib phase 3 clinical trials. J Dermatol Clin Res. 2015;3(3):1048.","journal-title":"J Dermatol Clin Res"},{"issue":"9","key":"284_CR40","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1001\/archderm.141.9.1146","volume":"141","author":"CR Charman","year":"2005","unstructured":"Charman CR, Venn AJ, Williams H. Measuring atopic eczema severity visually: which variables are most important to patients? Arch Dermatol. 2005;141(9):1146\u201351.","journal-title":"Arch Dermatol"},{"issue":"3","key":"284_CR41","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jaad.2007.10.010","volume":"58","author":"BG Bender","year":"2008","unstructured":"Bender BG, Ballard R, Canono B, et al. Disease severity, scratching, and sleep quality in patients with atopic dermatitis. J Am Acad Dermatol. 2008;58(3):415\u201320.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"284_CR42","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00403-013-1402-1","volume":"306","author":"FC Beikert","year":"2014","unstructured":"Beikert FC, Langenbruch AK, Radtke MA, et al. Willingness to pay and quality of life in patients with atopic dermatitis. Arch Dermatol Res. 2014;306(3):279\u201386.","journal-title":"Arch Dermatol Res"},{"key":"284_CR43","unstructured":"Simpson E, Beck LA, Wu R, et al. Correlation between clinical and patient-reported outcomes in patients with moderate-to-severe atopic dermatitis in a phase 2 clinical trial of dupilumab. Poster presented at the 23rd World Congress of Dermatology; Vancouver (BC); 8\u201313 June 2015."}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40257-017-0284-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-017-0284-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-017-0284-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T22:27:17Z","timestamp":1658960837000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40257-017-0284-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,26]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["284"],"URL":"https:\/\/doi.org\/10.1007\/s40257-017-0284-y","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,26]]}}}